|
MM-102
|
|
1417329-24-8
|
|
WZ 4003
|
|
1214265-58-3
|
|
Anacardic acid
|
|
16611-84-0
|
|
Givinostat (ITF2357)
|
|
732302-99-7
|
|
Isoxazole 9 (ISX-9)
|
|
832115-62-5
|
|
Veliparib
|
|
912444-00-9
|
|
UNC0638
|
|
1255580-76-7
|
|
Go 6983
|
|
133053-19-7
|
|
Sirtinol
|
|
410536-97-9
|
|
MK-4827 (Niraparib)
|
|
1038915-60-4
|
|
Thiazovivin
|
|
1226056-71-8
|
|
WM 1119
|
|
2055397-28-7
|
|
Serabelisib
|
|
1268454-23-4
|
|
Rapamycin
|
|
53123-88-9
|
|
Presatovir
|
|
1353625-73-6
|
|
GSK-J4 Hydrochloride
|
|
1797983-09-5
|
|
HTH-01-015
|
|
1613724-42-7
|
|
BAM 15
|
|
210302-17-3
|
|
1-(2,4-Dichlorophenyl)-N-1-piperidinyl-4-[[(1-pyrrolidinylsulfonyl)amino]methyl]-5-[5-[2-[4-(trifluoromethyl)phenyl]ethynyl]-2-thienyl]-1H-pyrazole-3-carboxamide
|
|
1429239-98-4
|
|
UPF 1069
|
|
1048371-03-4
|
|
HDAC6 inhibitor
|
|
1045792-66-2
|
|
DCC-2036
|
|
1020172-07-9
|
|
Elacestrant dihydrochloride
|
|
1349723-93-8
|
|
BMPsignalingagonistsb4
|
|
100874-08-6
|
|
GSK-J1
|
|
1373422-53-7
|
|
IPI-3063
|
|
1425043-73-7
|
|
NI 42
|
|
1884640-99-6
|
|
Sotrastaurin
|
|
425637-18-9
|
|
BEZ235
|
|
915019-65-7
|
|
PI-3065
|
|
955977-50-1
|
|
CU-T12-9
|
|
1821387-73-8
|
|
AZD5363
|
|
1143532-39-1
|
|
MRT67307
|
|
1190378-57-4
|
|
TK216
|
|
1903783-48-1
|
|
Aldose reductase-IN-1
|
|
1355612-71-3
|
|
MK2-IN-3
|
|
724711-21-1
|
|
Mizagliflozin (KWA 0711)
|
|
666843-10-3
|
|
AnsamitocinP-3
|
|
66584-72-3
|
|
A66
|
|
1166227-08-2
|
|
Vactosertib (TEW-7197)
|
|
1352608-82-2
|
|
MBQ-167
|
|
2097938-73-1
|
|
WYC-209
|
|
2131803-90-0
|
|
FMK
|
|
821794-92-7
|
|
KU-60019
|
|
925701-49-1
|
|
A-674563
|
|
552325-73-2
|
|
BYL719
|
|
1217486-61-7
|
|
GDC-0068
|
|
1001264-89-6
|
|
HS-173
|
|
1276110-06-5
|
|
Nilotinib (AMN-107)
|
|
641571-10-0
|
|
VX-150
|
|
1793080-72-4
|
|
Bosutinib (SKI-606)
|
|
380843-75-4
|
|
Bardoxolone
|
|
218600-44-3
|
|
XL765
|
|
1349796-36-6
|
|
TCS JNK 6o
|
|
894804-07-0
|
|
SU5204
|
|
186611-11-0
|
|
Enzastaurin (LY317615)
|
|
170364-57-5
|
|
INK-128
|
|
1224844-38-5
|
|
A-443654
|
|
552325-16-3
|
|
IKK-16 (IKK Inhibitor VII)
|
|
873225-46-8
|
|
ML385
|
|
846557-71-9
|
|
API-1
|
|
36707-00-3
|
|
Lifirafenib
|
|
1446090-79-4
|
|
YKL-05-099
|
|
1936529-65-5
|
|
DDD107498
|
|
1469439-69-7
|
|
Liproxstatin-1
|
|
950455-15-9
|
|
RK-33
|
|
1070773-09-9
|
|
PF-9366
|
|
72882-78-1
|
|
CM-272
|
|
1846570-31-7
|
|
AZ 628
|
|
878739-06-1
|
|
AR7
|
|
80306-38-3
|
|
1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]-
|
|
669764-18-5
|
|
Pyrimorph
|
|
868390-90-3
|
|
R-10015
|
|
2097938-51-5
|
|
VPC-80051
|
|
877969-69-2
|
|
Losmapimod
|
|
585543-15-3
|
|
PythiDC
|
|
1821370-71-1
|
|
PRE-084 hydrochloride
|
|
75136-54-8
|
|
NIBR-0213
|
|
1233332-14-3
|
|
VE-821
|
|
1232410-49-9
|
|
BGT226 (NVP-BGT226) maleate
|
|
1245537-68-1
|
|
GSK2636771
|
|
1372540-25-4
|
|
VPS34 inhibitor 1 (Compound 19)
|
|
1383716-46-8
|
|
PF-06726304
|
|
1616287-82-1
|
|
RY785
|
|
689297-68-5
|
|
BI-1347
|
|
2163056-91-3
|
|
RU-301
|
|
1110873-99-8
|
|
Tm2-115
|
|
1197196-47-6
|
|
CU-CPT-8m
|
|
125079-83-6
|
|
UT-34
|
|
2168525-92-4
|
|
DTHIB
|
|
897326-30-6
|
|
PS 48
|
|
1180676-32-7
|
|
SJ000291942
|
|
425613-09-8
|
|
IRAK inhibitor 1
|
|
1042224-63-4
|
|
ICA-105574
|
|
316146-57-3
|
|
CBL0137
|
|
1197996-80-7
|
|
Takinib
|
|
1111556-37-6
|
|
HS-1793
|
|
927885-00-5
|
|
MRT68921 HCl
|
|
2080306-21-2
|
|
GSK106 hydrochloride
|
|
1652591-82-6
|
|
LY-2940094
|
|
1307245-86-8
|